• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Chronic Myeloid Leukemia

Welcome to the Cancer Connect Leukemia Resource Center and Community. Our goal is to bring patients, caregivers, advocates and experts together in a single community where individuals benefit from expert-authored news and educational programming alongside a robust social network.

  • FDA Approves Scemblix for Chronic Myeloid Leukemia First-Line Treatment
    November 7, 2024

    FDA Approves Scemblix for Chronic Myeloid Leukemia First-Line Treatment

    Charles H. Weaver, MD
  • STAMP Inhibitor Scemblix for CML
    February 10, 2021

    STAMP Inhibitor Scemblix for CML

    Charles H. Weaver, MD
  • Ask the Expert: Chronic Myeloid Leukemia
    June 19, 2020

    Ask the Expert: Chronic Myeloid Leukemia

    Charles H. Weaver, MD
  • Gleevec® for CML: Long-lasting Anticancer Responses Confirmed
    March 13, 2020

    Gleevec® for CML: Long-lasting Anticancer Responses Confirmed

    Charles H. Weaver, MD
  • Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia
    March 6, 2020

    Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia

    Charles H. Weaver, MD
  • Chronic Myeloid Leukemia
    March 6, 2020

    Chronic Myeloid Leukemia

    Charles H. Weaver, MD
  • Bosulif (bosutinib) Treatment of Chronic Myelogenous Leukemia
    March 6, 2020

    Bosulif (bosutinib) Treatment of Chronic Myelogenous Leukemia

    Charles H. Weaver, MD
  • Tasigna® (nilotinib) Treatment for Chronic Myeloid Leukemia
    March 6, 2020

    Tasigna® (nilotinib) Treatment for Chronic Myeloid Leukemia

    Charles H. Weaver, MD
  • Sprycel® Therapy for Chronic Myeloid Leukemia
    March 6, 2020

    Sprycel® Therapy for Chronic Myeloid Leukemia

    Charles H. Weaver, MD
  • Could Flumatinib Replace Gleevec in Chronic-Phase Chronic Myeloid Leukemia?
    August 31, 2019

    Could Flumatinib Replace Gleevec in Chronic-Phase Chronic Myeloid Leukemia?

    Charles H. Weaver, MD
  • Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML
    May 7, 2019

    Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML

    Charles H. Weaver, MD
  • Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia
    May 3, 2019

    Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia

    Charles H. Weaver, MD
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...